Systematic Review of the Cost Effectiveness of Dapagliflozin Used to Treat Patients with Type 2 Diabetes Mellitus

Autor:	A. Moustakas, F. Ellen Loh, M. Labib, N. Girgis, J. Tsan, T. Duong
Rok vydání:	2018
Předmět:	medicine.medical_specialty Cost effectiveness business.industry Health Policy Public Health Environmental and Occupational Health Type 2 Diabetes Mellitus Type 2 diabetes medicine.disease Add on therapy chemistry.chemical_compound chemistry medicine Dapagliflozin Intensive care medicine business
Zdroj:	Value in Health. 21:S75
ISSN:	1098-3015
DOI:	10.1016/j.jval.2018.04.503
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2580fe97065d0bdd489ceb8b4616d8a4 https://doi.org/10.1016/j.jval.2018.04.503 Zobrazit plný text záznamu Full Text from ScienceDirect